There have been 50 recent insider transactions recorded for Inhibikase Therapeutics, Inc. (IKT), including 33 buys and 7 sells. Total insider buying was valued at $50.75M and total insider selling at $390.23K.
Notable insiders with recent activity include Munshi Amit, Aurentz Vincent, Cabell Christopher. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — IKT
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2026-02-21 |
Munshi Amit |
Director |
Return of Shares |
19,089 |
- |
- |
38,176 |
| 2026-02-21 |
Aurentz Vincent |
Director |
Return of Shares |
255,299 |
- |
- |
510,596 |
| 2026-02-21 |
Cabell Christopher |
President & Head of R&d |
Return of Shares |
338,282 |
- |
- |
676,564 |
| 2026-01-05 |
Mcintyre David |
Chief Financial Officer |
RSU Award |
986,319 |
$2.01 |
$1.98M |
986,319 |
| 2026-01-05 |
Iwicki Mark T |
Chief Executive Officer |
RSU Award |
4,982,706 |
$2.01 |
$10.02M |
4,982,706 |
| 2026-01-05 |
Cabell Christopher |
President & Head of R&d |
RSU Award |
900,117 |
$2.01 |
$1.81M |
900,117 |
| 2025-11-21 |
Sands Capital Life Sciences Pulse Fund Ii, L.p. |
10 Percent Owner |
Informative Buy |
2,068,965 |
$1.45 |
$3M |
13,018,965 |
| 2025-06-30 |
Berman Dennis N |
Director |
RSU Award |
108,176 |
$1.95 |
$210.94K |
108,176 |
| 2025-06-30 |
Munshi Amit |
Director |
RSU Award |
108,176 |
$1.95 |
$210.94K |
108,176 |
| 2025-06-30 |
Aurentz Vincent |
Director |
RSU Award |
108,176 |
$1.95 |
$210.94K |
108,176 |
| 2025-06-30 |
Bellini Roberto |
Director |
RSU Award |
108,176 |
$1.95 |
$210.94K |
108,176 |
| 2025-06-30 |
Kush Arvind |
Director |
RSU Award |
108,176 |
$1.95 |
$210.94K |
108,176 |
| 2025-06-30 |
Canner David |
Director |
RSU Award |
108,176 |
$1.95 |
$210.94K |
108,176 |
| 2025-06-06 |
Sands Capital Life Sciences Pulse Fund Ii, L.p. |
10 Percent Owner |
Unknown |
- |
- |
- |
10,950,000 |
| 2025-04-14 |
Mcintyre David |
Chief Financial Officer |
Unknown |
- |
- |
- |
10,285 |
| 2025-04-14 |
Mcintyre David |
Chief Financial Officer |
RSU Award |
1,775,539 |
$2.00 |
$3.55M |
1,775,539 |
| 2025-02-21 |
Munshi Amit |
Director |
RSU Award |
57,265 |
- |
- |
57,265 |
| 2025-02-21 |
Aurentz Vincent |
Director |
Unknown |
- |
- |
- |
765,895 |
| 2025-02-21 |
Cabell Christopher |
President & Head of R&d |
Unknown |
- |
- |
- |
1,014,846 |
| 2025-02-21 |
Iwicki Mark T |
Chief Executive Officer |
RSU Award |
602,346 |
$2.23 |
$1.34M |
602,346 |
| 2025-02-21 |
Aurentz Vincent |
Officer |
Unknown |
- |
- |
- |
- |
| 2025-02-21 |
Aurentz Vincent |
Director |
RSU Award |
134,427 |
$2.23 |
$299.77K |
134,427 |
| 2025-02-21 |
Cabell Christopher |
Officer |
Unknown |
- |
- |
- |
- |
| 2025-02-21 |
Cabell Christopher |
President & Head of R&d |
RSU Award |
1,100,705 |
$2.23 |
$2.45M |
1,100,705 |
| 2025-02-21 |
Iwicki Mark T |
Chief Executive Officer |
RSU Award |
602,346 |
$2.97 |
$1.79M |
602,346 |
| 2025-02-21 |
Aurentz Vincent |
Director |
RSU Award |
134,427 |
$2.97 |
$399.25K |
134,427 |
| 2025-02-21 |
Cabell Christopher |
President & Head of R&d |
RSU Award |
1,100,705 |
$2.97 |
$3.27M |
1,100,705 |
| 2025-02-17 |
Iwicki Mark T |
Chief Executive Officer |
RSU Award |
1,794,291 |
$2.35 |
$4.22M |
1,794,291 |
| 2025-02-14 |
Berman Dennis N |
Director |
RSU Award |
39,620 |
$2.35 |
$93.11K |
39,620 |
| 2025-02-14 |
Iwicki Mark T |
Officer |
Unknown |
- |
- |
- |
- |
| 2025-02-14 |
Iwicki Mark T |
Chief Executive Officer |
RSU Award |
4,373,857 |
$2.35 |
$10.28M |
4,373,857 |
| 2025-02-14 |
Munshi Amit |
Director |
RSU Award |
56,600 |
$2.35 |
$133.01K |
56,600 |
| 2025-02-14 |
Freeman Roy Lester |
Director |
RSU Award |
22,640 |
$2.35 |
$53.2K |
22,640 |
| 2025-02-14 |
Bellini Roberto |
Director |
RSU Award |
73,580 |
$2.35 |
$172.91K |
73,580 |
| 2025-02-14 |
Kush Arvind |
Director |
RSU Award |
56,600 |
$2.35 |
$133.01K |
56,600 |
| 2025-02-14 |
Canner David |
Director |
RSU Award |
22,640 |
$2.35 |
$53.2K |
22,640 |
| 2025-01-21 |
Berman Dennis N |
Director |
Return of Shares |
3,780 |
$17.52 |
$66.23K |
- |
| 2025-01-21 |
Freeman Roy Lester |
Director |
Return of Shares |
6,667 |
$4.86 |
$32.4K |
- |
| 2025-01-21 |
Werner Milton H. |
President and CEO |
Return of Shares |
45,000 |
$2.16 |
$97.2K |
- |
| 2025-01-21 |
Lees-rolfe Garth |
Chief Financial Officer |
Return of Shares |
90,000 |
$2.16 |
$194.4K |
- |
| 2025-01-03 |
Berman Dennis N |
Director |
RSU Award |
172,191 |
$1.45 |
$249.68K |
172,191 |
| 2025-01-03 |
Freeman Roy Lester |
Director |
RSU Award |
172,191 |
$1.45 |
$249.68K |
172,191 |
| 2025-01-03 |
Werner Milton H. |
President and CEO |
RSU Award |
2,207,671 |
$1.45 |
$3.2M |
2,207,671 |
| 2025-01-03 |
Lees-rolfe Garth |
Chief Financial Officer |
RSU Award |
235,383 |
$1.45 |
$341.31K |
235,383 |
| 2024-10-21 |
Munshi Amit |
Officer |
Unknown |
- |
- |
- |
- |
| 2024-10-21 |
Munshi Amit |
Director |
RSU Award |
60,000 |
$2.22 |
$133.2K |
60,000 |
| 2024-10-21 |
Bellini Roberto |
Officer |
Unknown |
- |
- |
- |
- |
| 2024-10-21 |
Bellini Roberto |
Director |
RSU Award |
60,000 |
$2.22 |
$133.2K |
60,000 |
| 2024-10-21 |
Kush Arvind |
Officer |
Unknown |
- |
- |
- |
- |
| 2024-10-21 |
Kush Arvind |
Director |
RSU Award |
60,000 |
$2.22 |
$133.2K |
60,000 |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry
